ELDN Eledon Pharmaceuticals
- 2.300
- +0.010+0.44%
- 2.360
- +0.060+2.61%
Eledon Pharmaceuticals News
Express News | Watching Eledon Pharmaceuticals, Acumen Pharmaceuticals; Shares See Volume On TipRanks Article Titled "These 2 'Strong Buy' Penny Stocks Are Poised for Over 300% Gains, Say Analysts"
Eledon Pharmaceuticals Risks Shareholder Equity Dilution Amidst Private Placement and Potential Stock Issuances
Eledon Pharmaceuticals: A Strong Buy on the Back of Promising Clinical Trials and a Solid Financial Footing
Express News | Eledon Pharma Q4 2023 GAAP EPS $(0.32) Beats $(0.39) Estimate
Eledon PhaDrmaceuticals 4Q Loss/Shr 32c >ELDN
Eledon PhaDrmaceuticals 4Q Loss/Shr 32c >ELDN
Press Release: Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results Enrolled 12 participants in Phase 2 BESTOW trial evaluating tegoprubart for the prevention of kidney r
Express News | Eledon Pharmaceuticals Reports 12th Participant Enrolled In Phase 2 BESTOW Trial Evaluating Tegoprubart For Prevention Of Organ Rejection
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
IRVINE, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ:ELDN) today announced the enrollment of the 12th participant on March 23, 2024, in the Company's ongoing Phase 2 BESTOW
Eledon Pharmaceuticals' Tegoprubart Shows Best-in-Class Potential in Organ Transplantation
Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Medtronic (MDT) and Mediwound (MDWD)
Eledon Pharmaceuticals: A Buy Rating on Breakthrough Organ Transplant Solutions
Sector Update: Health Care Stocks Higher in Late Afternoon Trading
Health care stocks were higher late Thursday afternoon, with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.3%. The iShares Biotechnology ETF (IBB) climb
Sector Update: Health Care
Health care stocks rose late Thursday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) rising 0.3%. The iShares Biotechnology ETF (IBB) climbed 0
Eledon Pharmaceuticals Says Tegoprubart Used in Kidney Transplant From Pig to Human
Eledon Pharmaceuticals (ELDN) said Thursday its tegoprubart was used as a part of the immunosuppressive treatment regimen after a kidney transplant from a genetically modified pig to a 62-year-old man
World's First Pig-to-human Kidney Transplant Performed in U.S
Eledon Pharmaceuticals Reports Recent Business Milestones
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
Reported updated data from ongoing Phase 1b trial in kidney transplantation demonstrating tegoprubart treatment successfully prevented kidney transplant rejection and was generally safe and well-tolerated Dosed first
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
IRVINE, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ:ELDN) today announced that on December 1, 2023, the Company's Compensation Committee granted our new Chief Medical
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
IRVINE, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ:ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will present a company overview at
Analysts Offer Insights on Healthcare Companies: Recursion Pharmaceuticals (RXRX), Edgewise Therapeutics (EWTX) and Eledon Pharmaceuticals (ELDN)
Analysis
Price Target
No Data
